Published in Arthritis Res Ther on March 03, 2011
The Effect of Tart Cherry Juice on Risk of Gout Attacks | NCT03621215
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis (2014) 2.36
Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. Clin Pharmacol Ther (2012) 1.72
Reduced glomerular function and prevalence of gout: NHANES 2009-10. PLoS One (2012) 1.60
Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol (2015) 1.57
Epidemiology of gout. Rheum Dis Clin North Am (2014) 1.28
Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann Rheum Dis (2014) 1.17
Management of gout in general practice--a systematic review. Clin Rheumatol (2014) 0.98
Risk factors for pseudogout in the general population. Rheumatology (Oxford) (2012) 0.97
Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout. Arthritis Care Res (Hoboken) (2013) 0.89
Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis. Biomed Res Int (2015) 0.88
Incident gout in women and association with obesity in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Med (2012) 0.85
Determinants of the prevalence of gout in the general population: a systematic review and meta-regression. Eur J Epidemiol (2014) 0.85
A meta-analysis of alcohol consumption and the risk of gout. Clin Rheumatol (2013) 0.82
Relationship between inflammatory cytokines and uric acid levels with adverse cardiovascular outcomes in patients with stable coronary heart disease. PLoS One (2012) 0.82
Low-dose aspirin use and recurrent gout attacks. Ann Rheum Dis (2013) 0.81
Body mass index and the risk of gout: a systematic review and dose-response meta-analysis of prospective studies. Eur J Nutr (2014) 0.81
Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan. Ann Rheum Dis (2013) 0.81
The emerging role of biotechnological drugs in the treatment of gout. Biomed Res Int (2014) 0.79
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis. Adv Ther (2016) 0.77
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012. Semin Arthritis Rheum (2016) 0.76
Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. Arthritis Res Ther (2015) 0.76
[Diagnosis and management of gout in Austria. Survey of current practice considering the EULAR recommendations]. Z Rheumatol (2014) 0.76
A meta-analysis of the associations between the Q141K and Q126X ABCG2 gene variants and gout risk. Int J Clin Exp Pathol (2015) 0.76
The Obesity Paradox in Recurrent Attacks of Gout in Observational Studies: Clarification and Remedy. Arthritis Care Res (Hoboken) (2016) 0.75
Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications. Ther Adv Musculoskelet Dis (2016) 0.75
The 3-Year Incidence of Gout in Elderly Patients with CKD. Clin J Am Soc Nephrol (2017) 0.75
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. Rheumatol Ther (2016) 0.75
Clinical characteristics of early- and late-onset gout: A cross-sectional observational study from a Chinese gout clinic. Medicine (Baltimore) (2016) 0.75
Tophaceous gout in a female premenopausal patient with an unexpected diagnosis of glycogen storage disease type Ia: a case report and literature review. Clin Rheumatol (2016) 0.75
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
Pathogenesis of gout. Ann Intern Med (2005) 4.50
Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care (2004) 4.39
Alcohol intake and risk of incident gout in men: a prospective study. Lancet (2004) 4.12
Clinical practice. Gout. N Engl J Med (2003) 3.78
Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis (2005) 3.53
Gout and risk of Parkinson disease: a prospective study. Neurology (2007) 3.09
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis (2007) 2.89
Epidemiology of gout: is the incidence rising? J Rheumatol (2002) 2.80
Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med (2005) 2.80
The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis (2002) 2.26
Omeprazole, other antiulcer drugs and newly diagnosed gout. Br J Clin Pharmacol (1997) 1.99
Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2007) 1.95
Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J (1973) 1.88
Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis (2007) 1.86
Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther (2006) 1.80
Menopause, postmenopausal hormone use and serum uric acid levels in US women--the Third National Health and Nutrition Examination Survey. Arthritis Res Ther (2008) 1.75
Cyclosporine-induced hyperuricemia and gout. N Engl J Med (1989) 1.67
Epidemiology of hyperuricemia and gout. Am J Manag Care (2005) 1.65
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J (1997) 1.55
The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int (2003) 1.48
Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis (2006) 1.39
Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol (2005) 1.28
Impact of diabetes against the future risk of developing gout. Ann Rheum Dis (2010) 1.24
Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey. Rheumatology (Oxford) (2008) 1.24
Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol (2000) 1.20
Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis (1998) 1.16
Gout, not induced by diuretics? A case-control study from primary care. Ann Rheum Dis (2005) 1.08
Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis (2009) 1.03
Gout, diuretics and the kidney. Ann Rheum Dis (2006) 1.02
Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007. Ann Rheum Dis (2008) 1.01
Plasma hypoxanthine and exercise. Am Rev Respir Dis (1987) 0.98
Progesterone increases glomerular filtration rate, urinary kallikrein excretion and uric acid clearance in normal women. Braz J Med Biol Res (1988) 0.90
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum (2011) 6.36
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57
Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health (2008) 4.49
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum (2008) 4.20
Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr (2009) 4.04
Epidemiology of stomach cancer. Methods Mol Biol (2009) 3.72
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum (2002) 3.55
Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum (2012) 3.51
Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum (2006) 3.26
Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum (2003) 3.13
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem (2004) 2.95
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2010) 2.94
Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2008) 2.91
Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med (2007) 2.89
Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol (2010) 2.86
Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study. Ann Intern Med (2014) 2.76
The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol (2008) 2.60
Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation (2007) 2.58
Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol (2010) 2.29
Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J (2008) 2.26
Methodologic challenges in studying risk factors for progression of knee osteoarthritis. Arthritis Care Res (Hoboken) (2010) 2.20
A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care (2006) 2.18
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16
Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2011) 2.14
Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med (2002) 2.13
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med (2012) 2.12
Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum (2009) 2.07
Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ (2014) 2.06
Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension (2007) 2.05
Vitamin C intake and serum uric acid concentration in men. J Rheumatol (2008) 2.05
Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer (2003) 1.98
Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med (2007) 1.95
Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol (2004) 1.95
Older smokers' motivation and attempts to quit smoking: epidemiological insight into the question of lifestyle versus addiction. Dtsch Arztebl Int (2009) 1.92
Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum (2003) 1.92
Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol (2009) 1.91
Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol (2006) 1.90
Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records. Pharmacoepidemiol Drug Saf (2011) 1.85
Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol (2012) 1.80
Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chem (2012) 1.76
Menopause, postmenopausal hormone use and serum uric acid levels in US women--the Third National Health and Nutrition Examination Survey. Arthritis Res Ther (2008) 1.75
Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem (2006) 1.75
Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One (2008) 1.75
Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol (2008) 1.69
Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart (2012) 1.64
Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis (2012) 1.63
Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med (2006) 1.62
Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum (2010) 1.61
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol (2006) 1.56
Epidemiology of Helicobacter pylori infection. Helicobacter (2004) 1.56
Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum (2002) 1.52
Recurrent abdominal pain in children: evidence from a population-based study that social and familial factors play a major role but not Helicobacter pylori infection. J Psychosom Res (2003) 1.51
Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J (2012) 1.51
The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int (2003) 1.48
The genetics of hyperuricaemia and gout. Nat Rev Rheumatol (2012) 1.47
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
Commentary: effect of obesity on mortality: comment on article by Banack and Kaufman. Epidemiology (2014) 1.45
Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation. Thromb Haemost (2013) 1.43
Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause (2006) 1.43
Incidence and risk factors for atrial fibrillation in patients with newly diagnosed heart failure. J Cardiovasc Med (Hagerstown) (2016) 1.38
Acquisition of Helicobacter pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings. Am J Gastroenterol (2009) 1.37
Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med (2008) 1.34
The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study. J Clin Epidemiol (2005) 1.32
Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern Med (2006) 1.30
Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer. Pharmacoepidemiol Drug Saf (2009) 1.30
Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach. Eur J Cardiovasc Prev Rehabil (2007) 1.28
Association of diabetes and body mass index with levels of prostate-specific antigen: implications for correction of prostate-specific antigen cutoff values? Cancer Epidemiol Biomarkers Prev (2009) 1.25
Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis (2010) 1.25
Impact of diabetes against the future risk of developing gout. Ann Rheum Dis (2010) 1.24
Morbidity associated with sleep disorders in primary care: a longitudinal cohort study. Prim Care Companion J Clin Psychiatry (2007) 1.23
Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol (2004) 1.21
Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease. Neurology (2006) 1.21
Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med (2007) 1.20
Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int (2003) 1.17
Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival. Diabetes Care (2012) 1.12
Adiponectin and leptin in maternal serum, cord blood, and breast milk. Clin Chem (2006) 1.12
Nonsteroidal anti-inflammatory drugs and risk of lung cancer. Int J Cancer (2007) 1.12
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) (2013) 1.11
Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.11
Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology (Oxford) (2012) 1.10
Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter (2006) 1.09
Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. Eur Heart J (2009) 1.09
Creating a blended learning module in an online master study programme in oncology. Educ Health (Abingdon) (2015) 1.09
Allopurinol and mortality in hyperuricaemic patients. Rheumatology (Oxford) (2009) 1.08
Hyaluronic acid injections relieve knee pain. J Fam Pract (2005) 1.08
G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitus. Circulation (2004) 1.07
The epidemiology of uric acid and fructose. Semin Nephrol (2011) 1.06
Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis. Atherosclerosis (2005) 1.05
Respiratory medications and the risk of cardiac arrhythmias. Epidemiology (2005) 1.05
Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population. BMC Musculoskelet Disord (2011) 1.04
Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide. Ann Rheum Dis (2011) 1.03
Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy. Gastroenterology (2011) 1.03
Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis (2009) 1.03
Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer (2007) 1.03
Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis. Am J Epidemiol (2012) 1.02